These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9041480)

  • 1. Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands.
    Bradley LA; Haddow JE; Palomaki GE
    J Med Screen; 1996; 3(4):171-7. PubMed ID: 9041480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population screening for haemochromatosis: a unifying analysis of published intervention trials.
    Bradley LA; Haddow JE; Palomaki GE
    J Med Screen; 1996; 3(4):178-84. PubMed ID: 9041481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron status markers in hereditary haemochromatosis: distinction between individuals being homozygous and heterozygous for the haemochromatosis allele.
    Milman N
    Eur J Haematol; 1991 Oct; 47(4):292-8. PubMed ID: 1954989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA determinants in idiopathic haemochromatosis.
    Milman N; Graudal N; Nielsen LS; Sørensen SA
    Dan Med Bull; 1985 Oct; 32(5):262-4. PubMed ID: 4053696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis.
    Yeap BB; Divitini ML; Gunton JE; Olynyk JK; Beilby JP; McQuillan B; Hung J; Knuiman MW
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):525-32. PubMed ID: 24953981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based study of the clinical expression of the hemochromatosis gene.
    Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
    N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elevated serum ferritin and hemochromatosis in general practice].
    Mouland G; Bratland B; Hornnes MB; Asser HP; Lier J; Reiso H; Rygh E
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):20-2. PubMed ID: 15643457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between genotype, assessed by HLA typing, and phenotypic expression of iron status markers in families of 29 probands with hereditary haemochromatosis.
    Milman N; Fenger K; Graudal NA; Nielsen LS
    Dan Med Bull; 1994 Jun; 41(3):366-70. PubMed ID: 7924465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinction between homozygous and heterozygous subjects with hereditary haemochromatosis using iron status markers and receiver operating characteristic (ROC) analysis.
    Milman N; Albeck MJ
    Eur J Clin Chem Clin Biochem; 1995 Feb; 33(2):95-8. PubMed ID: 7632826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic efficacy of screening tests for hereditary hemochromatosis.
    Borwein S; Ghent CN; Valberg LS
    Can Med Assoc J; 1984 Oct; 131(8):895-901. PubMed ID: 6593112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of cancer by transferrin saturation levels and haemochromatosis genotype: population-based study and meta-analysis.
    Ellervik C; Tybjaerg-Hansen A; Nordestgaard BG
    J Intern Med; 2012 Jan; 271(1):51-63. PubMed ID: 21605201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing manifestations of hereditary haemochromatosis through population based screening.
    Haddow JE; Ledue TB
    J Med Screen; 1994 Jan; 1(1):16-21. PubMed ID: 8790482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing for haemochromatosis in the diabetic clinic.
    George DK; Evans RM; Crofton RW; Gunn IR
    Ann Clin Biochem; 1995 Nov; 32 ( Pt 6)():521-6. PubMed ID: 8579282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of subjects with abnormal iron studies: role of the hepatic iron index.
    Chapman BA; Horton DM; Burt MJ; Romeril KR; Walmsley TA; Grant SJ; George P
    N Z Med J; 1994 Dec; 107(991):504-7. PubMed ID: 7830980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin, blood donation, iron stores and haemochromatosis.
    Worwood M; Darke C
    Transfus Med; 1993 Mar; 3(1):21-8. PubMed ID: 8038893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemochromatosis gene mutations Cys282Tyr and His63Asp are not increased in Type 2 diabetic patients compared with the Canterbury (New Zealand) general population.
    Florkowski CM; George PM; Willis JA; Stott MK; Burt MJ; Upton JD; Nesbit J; Walmsley TA; Scott RS
    Diabetes Res Clin Pract; 1999 Mar; 43(3):199-203. PubMed ID: 10369430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of primary hemochromatosis].
    Swinkels DW; Marx JJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.
    Bulaj ZJ; Griffen LM; Jorde LB; Edwards CQ; Kushner JP
    N Engl J Med; 1996 Dec; 335(24):1799-805. PubMed ID: 8943161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.